Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device
Aim: To test the short term efficacy and safety of an infrared warm compression device (IWCD, Eye Hot, Cept Co, Tokyo, Japan) as treatment for non-inflamed meibomian gland dysfunction (MGD). Methods: 37 subjects with non-inflamed obstructive MGD, with and without aqueous tear deficiency (ATD) dry ey...
Saved in:
Published in | British journal of ophthalmology Vol. 86; no. 12; pp. 1403 - 1407 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
BMA House, Tavistock Square, London, WC1H 9JR
BMJ Publishing Group Ltd
01.12.2002
BMJ BMJ Publishing Group LTD Copyright 2002 British Journal of Ophthalmology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Aim: To test the short term efficacy and safety of an infrared warm compression device (IWCD, Eye Hot, Cept Co, Tokyo, Japan) as treatment for non-inflamed meibomian gland dysfunction (MGD). Methods: 37 subjects with non-inflamed obstructive MGD, with and without aqueous tear deficiency (ATD) dry eye, participated in a prospective non-comparative interventional case series. Symptom scores, face scores, tear evaporation rates, fluorescein and rose bengal vital staining, tear break up time (BUT), Schirmer test, meibomian gland obstruction, and meibography were compared before and after 2 weeks of therapy. Results: In a total of 37 cases, total subjective symptom scores and subjective face scores improved significantly, from 12.3 (SD 5.9) to 8.4 (6.1), and from 7.0 (1.7) to 5.3 (2.0) (both p <0.0001). The results for tear evaporation rates during forced blinking (p = 0.002), fluorescein staining (p = 0.03), rose bengal staining (p = 0.03), BUT (p <0.0001), and meibomian gland orifice obstruction score (p <0.0001) had also improved significantly at the end of the 2 week period of infrared thermotherapy. No complaints and/or complications of the IWCD were reported. Conclusion: The IWCD was effective and safe for the treatment of MGD. Improved tear stability associated with release of meibum is a possible mechanism of this treatment. |
---|---|
Bibliography: | PMID:12446375 istex:8CFB807475FA11F0BFB03C5CCF2BC7791CF8B618 href:bjophthalmol-86-1403.pdf ark:/67375/NVC-263XSVC6-V local:0861403 Correspondence to: Eiki Goto, MD, Department of Ophthalmology, Tokyo Dental College, Sugano 5-11-13, Ichikawa-shi, Chiba 272-8513, Japan; eikigoto@nifty.com ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Correspondence to: Eiki Goto, MD, Department of Ophthalmology, Tokyo Dental College, Sugano 5-11-13, Ichikawa-shi, Chiba 272-8513, Japan; eikigoto@nifty.com |
ISSN: | 0007-1161 1468-2079 |
DOI: | 10.1136/bjo.86.12.1403 |